Project Details
Description
A multi-centre, randomised, double-blinded, controlled, dose-escalation trial on safety and efficacy of activated recombiant FVII analogue
| Status | Finished |
|---|---|
| Effective start/end date | 5/22/07 → 12/31/20 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.